↓ Skip to main content

Albuterol Improves Response to Levodopa and Increases Skeletal Muscle Mass in Patients With Fluctuating Parkinson Disease

Overview of attention for article published in Clinical Neuropharmacology, July 2003
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)

Mentioned by

patent
14 patents
reddit
2 Redditors

Readers on

mendeley
61 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Albuterol Improves Response to Levodopa and Increases Skeletal Muscle Mass in Patients With Fluctuating Parkinson Disease
Published in
Clinical Neuropharmacology, July 2003
DOI 10.1097/00002826-200307000-00011
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 61 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 6 10%
Other 5 8%
Student > Bachelor 5 8%
Student > Master 5 8%
Student > Doctoral Student 4 7%
Other 12 20%
Unknown 24 39%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 12 20%
Pharmacology, Toxicology and Pharmaceutical Science 5 8%
Nursing and Health Professions 4 7%
Neuroscience 4 7%
Agricultural and Biological Sciences 3 5%
Other 8 13%
Unknown 25 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2026.
All research outputs
#7,223,680
of 34,115,020 outputs
Outputs from Clinical Neuropharmacology
#236
of 1,182 outputs
Outputs of similar age
#17,723
of 75,705 outputs
Outputs of similar age from Clinical Neuropharmacology
#2
of 4 outputs
Altmetric has tracked 34,115,020 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,182 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 75,705 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.